Cargando…
Continuous flow synthesis of a pharmaceutical intermediate: a computational fluid dynamics approach†
Continuous flow chemistry has the potential to greatly improve efficiency in the synthesis of active pharmaceutical ingredients (APIs); however, the optimization of these processes can be complicated by a large number of variables affecting reaction success. In this work, a screening design of exper...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745113/ https://www.ncbi.nlm.nih.gov/pubmed/33456973 http://dx.doi.org/10.1039/c8re00252e |
_version_ | 1783624550386237440 |
---|---|
author | Armstrong, Cameron T. Pritchard, Cailean Q. Cook, Daniel W. Ibrahim, Mariam Desai, Bimbisar K. Whitham, Patrick J. Marquardt, Brian J. Chen, Yizheng Zoueu, Jeremie T. Bortner, Michael J. Roper, Thomas D. |
author_facet | Armstrong, Cameron T. Pritchard, Cailean Q. Cook, Daniel W. Ibrahim, Mariam Desai, Bimbisar K. Whitham, Patrick J. Marquardt, Brian J. Chen, Yizheng Zoueu, Jeremie T. Bortner, Michael J. Roper, Thomas D. |
author_sort | Armstrong, Cameron T. |
collection | PubMed |
description | Continuous flow chemistry has the potential to greatly improve efficiency in the synthesis of active pharmaceutical ingredients (APIs); however, the optimization of these processes can be complicated by a large number of variables affecting reaction success. In this work, a screening design of experiments was used to compare computational fluid dynamics (CFD) simulations with experimental results. CFD simulations and experimental results both identified the reactor residence time and reactor temperature as the most significant factors affecting product yield for this reaction within the studied design space. A point-to-point comparison of the results showed absolute differences in product yield as low as 2.4% yield at low residence times and up to 19.1% yield at high residence times with strong correlation between predicted and experimental percent yields. CFD was found to underestimate the product yields at low residence times and overestimate at higher residence times. The correlation in predicted product yield and the agreement in identifying significant factors in reaction performance reveals the utility of CFD as a valuable tool in the design of continuous flow tube reactors with significantly reduced experimentation. |
format | Online Article Text |
id | pubmed-7745113 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | The Royal Society of Chemistry |
record_format | MEDLINE/PubMed |
spelling | pubmed-77451132021-01-15 Continuous flow synthesis of a pharmaceutical intermediate: a computational fluid dynamics approach† Armstrong, Cameron T. Pritchard, Cailean Q. Cook, Daniel W. Ibrahim, Mariam Desai, Bimbisar K. Whitham, Patrick J. Marquardt, Brian J. Chen, Yizheng Zoueu, Jeremie T. Bortner, Michael J. Roper, Thomas D. React Chem Eng Article Continuous flow chemistry has the potential to greatly improve efficiency in the synthesis of active pharmaceutical ingredients (APIs); however, the optimization of these processes can be complicated by a large number of variables affecting reaction success. In this work, a screening design of experiments was used to compare computational fluid dynamics (CFD) simulations with experimental results. CFD simulations and experimental results both identified the reactor residence time and reactor temperature as the most significant factors affecting product yield for this reaction within the studied design space. A point-to-point comparison of the results showed absolute differences in product yield as low as 2.4% yield at low residence times and up to 19.1% yield at high residence times with strong correlation between predicted and experimental percent yields. CFD was found to underestimate the product yields at low residence times and overestimate at higher residence times. The correlation in predicted product yield and the agreement in identifying significant factors in reaction performance reveals the utility of CFD as a valuable tool in the design of continuous flow tube reactors with significantly reduced experimentation. The Royal Society of Chemistry 2019-01-30 /pmc/articles/PMC7745113/ /pubmed/33456973 http://dx.doi.org/10.1039/c8re00252e Text en © 2019 The Royal Society of Chemistry http://creativecommons.org/licenses/by/3.0/ This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. (http://creativecommons.org/licenses/by/3.0/). |
spellingShingle | Article Armstrong, Cameron T. Pritchard, Cailean Q. Cook, Daniel W. Ibrahim, Mariam Desai, Bimbisar K. Whitham, Patrick J. Marquardt, Brian J. Chen, Yizheng Zoueu, Jeremie T. Bortner, Michael J. Roper, Thomas D. Continuous flow synthesis of a pharmaceutical intermediate: a computational fluid dynamics approach† |
title | Continuous flow synthesis of a pharmaceutical intermediate: a computational fluid dynamics approach† |
title_full | Continuous flow synthesis of a pharmaceutical intermediate: a computational fluid dynamics approach† |
title_fullStr | Continuous flow synthesis of a pharmaceutical intermediate: a computational fluid dynamics approach† |
title_full_unstemmed | Continuous flow synthesis of a pharmaceutical intermediate: a computational fluid dynamics approach† |
title_short | Continuous flow synthesis of a pharmaceutical intermediate: a computational fluid dynamics approach† |
title_sort | continuous flow synthesis of a pharmaceutical intermediate: a computational fluid dynamics approach† |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745113/ https://www.ncbi.nlm.nih.gov/pubmed/33456973 http://dx.doi.org/10.1039/c8re00252e |
work_keys_str_mv | AT armstrongcameront continuousflowsynthesisofapharmaceuticalintermediateacomputationalfluiddynamicsapproach AT pritchardcaileanq continuousflowsynthesisofapharmaceuticalintermediateacomputationalfluiddynamicsapproach AT cookdanielw continuousflowsynthesisofapharmaceuticalintermediateacomputationalfluiddynamicsapproach AT ibrahimmariam continuousflowsynthesisofapharmaceuticalintermediateacomputationalfluiddynamicsapproach AT desaibimbisark continuousflowsynthesisofapharmaceuticalintermediateacomputationalfluiddynamicsapproach AT whithampatrickj continuousflowsynthesisofapharmaceuticalintermediateacomputationalfluiddynamicsapproach AT marquardtbrianj continuousflowsynthesisofapharmaceuticalintermediateacomputationalfluiddynamicsapproach AT chenyizheng continuousflowsynthesisofapharmaceuticalintermediateacomputationalfluiddynamicsapproach AT zoueujeremiet continuousflowsynthesisofapharmaceuticalintermediateacomputationalfluiddynamicsapproach AT bortnermichaelj continuousflowsynthesisofapharmaceuticalintermediateacomputationalfluiddynamicsapproach AT roperthomasd continuousflowsynthesisofapharmaceuticalintermediateacomputationalfluiddynamicsapproach |